Infan Industria Quimica Farmaceutica Nacional Report issue

For profit Phase 2 Phase 3
Founded: Caruaru Brazil (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2017
NCT03084952
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Infan Industria Quimica Farmaceutica Nacional

Active Ingredients

Drugs in Phase 3 Trials (4)

amoxicillin (1 trial)

clarithromycin (biaxin) (1 trial)

omeprazole (prilosec) (1 trial)

schinus terebinthifolius (1 trial)

Drugs in Phase 2 Trials (1)

18-methoxycoronaridine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Gastritis (Phase 3)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5